Pretreatment with tetrandrine has protective effects against isoproterenol-induced myocardial infarction in rabbits

In Vivo

Volumn 24, Issue 3, 2010, Pages 265-270

  Pinelli, Arnaldo ^a   Trivulzio, Silvio ^a   Brenna, Sergio ^b   Galmozzi, Gustavo ^c   Rossoni, Giuseppe ^a  

^a Department of Pharmacology ^*  (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

c troponin I; Cardiac necrosis markers; ECG; Histology; Isoproterenol; Malondialdehyde; Myocardial infarction; Myoglobin; Partial thromboplastin time; Rabbits; Tetrandrine

Indexed keywords

ISOPRENALINE; MALONALDEHYDE; MYOGLOBIN; TETRANDRINE; TROPONIN I;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HEART PROTECTION; HISTOPATHOLOGY; MALE; NONHUMAN; PHYTOTHERAPY; RABBIT; ST SEGMENT;

EID: 77954095679     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. The Merk Index. 12 ed.. New Jersey. Merk Co, p. 1577, 1996.
2. Chen YJ: Potential role of tetrandrine in cancer therapy. Acta Pharm Sinica 23: 1102-1106, 2002. (Pubitemid 35470334)
3. Chang TM, Chao KC and Lu FH: The cardiovascular effects of tetrandrine and dimethyl-tetrandrine. Acta Pharm Sinica 6: 147-153, 1958.
4. Zeng FD, Fang DC, Leng DM and Lu FH: Influence of tetrandrine on the left ventricular function and peripheral blood vessels in canines. Acta Pharm Sinica 17: 561-565, 1982.
5. Gao Y, Chang MY, Mao HY, Chao HY and Chen DH: The clinical observation of tetrandrine in the treatment of 270 cases of hypertension patients and hypertensive crisis. J Chin Int Med 13: 504-507, 1965.
6. Department of Pharmacology. Wuhan Medical College and Health Department, Wuhan Textile Factory: A clinical study of antihypertensive effect of tetrandrine. Chin Med J 92: 193-198, 1979.
7. Cha L, Qian JQ and Lu FH: Antiarrhythmic action of tetrandrine and the total alkaloids of Sophora flavescens. Acta Pharmacologica Sinica 2: 26-28, 1981.
8. Yu XC, Wu S, Wang GY, Shan J, Wong TM, Chen CF and Pang KT: Cardiac effects of the extract and active components of radix Stephaniae tetrandrae. II. Myocardial infarct, arrhythmias, coronary arterial flow and heart rate in the isolated perfused rat heart. Life Sci 68: 2863-2872, 2001.
9. Chen H, Chen SC, Zhang TH, Tian HC, Guan Y and Su DF: Protective effects of silybin and tetrandrine on the outcome of spontaneously hypertensive rats subjected to acute coronary artery occlusion. Int J Cardiol 41: 103-108, 1993.
10. Yu XC, Wu S, Chen CF, Pang KT and Wong TM: Antihypertensive and anti-arrhythmic effects of an extract of radix Stephaniae tetrandrae in the rat. J Phar Pharmacol 56: 115-122, 2004.
11. Shen YC, Chen CF and Sung YJ: Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br J Pharmacol 128: 1593-1601, 1999.
12. Kim HS, Zhang YH and Yun YP: Effects of tetrandrine and fangchinoline on experimental thrombosis in mice and human platelet aggregation. Planta Med 65: 135-138, 1999.
13. Blasig IE, Blasig R and Lowe H: Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium. Biomed Biochim Acta 43: S171-S174, 1984.
14. Pinelli A, Trivulzio S, Tomasoni L, Brenna S, Bonacina E and Accinni R: Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. Eur J Pharmaceutical Sci 23: 277-285, 2004.
15. Pinelli A, Trivulzio S, Tomasoni L, Bertolini B, Brenna S, Bonacina E and Vignati S: Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. Fund Clin Pharmacol 18: 657-667, 2004.
16. O'Brien PJ, Dameron GW, Beck ML, Kang YJ, Erickson BK, Di Battista TH, Miller KE, Jackson KN and Mittelstadt S: Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci 47: 486-495, 1997.
17. Bodor GS, Porter S, Landt Y and Ladenson JH: Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 38: 2203-2214, 1992.
18. O'Brien PJ, Lant Y and Ladenson JH: Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem 43: 2333-2338, 1997.
19. Plebani M and Zaninotto M: Diagnostic strategies using myoglobin measurement in myocardial infarction. Clin Chim Acta 272: 69-77, 1998. (Pubitemid 28179618)
20. AFIP: Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. 3rd ed. New York, McGraw-Hill book Company, 1968.
21. Cighetti G, Debiasi S, Paroni R and Allevi P: Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal Biochem 266: 222-229, 1999.
22. Pasquinelli F: Diagnostica e Tecniche di Laboratorio. Firenze. Rosini Editrice, 1997.
23. Armitage P: Statistica Medica. 10th ed., Milano, Feltrinelli, 1991.
24. Bertinchant JP, Robert E, Polge A, Marty-Double C, Fabbro-Peray P, Poirey S, Aya G, Juan JM, Ledermann B, de la Coussaye JE and Dauzat M: Comparison of the diagnostic value of cardiac troponin I and T determination for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta 295: 13-28, 2000.
25. Bertsch T, Bleuel H, Aufenanger J and Rebel W: Comparison of cardiac troponin T and cardiac troponin I concentrations in peripheral blood during orciprenaline-induced tachycardia in rats. Exp Toxicol Pathol 49: 467-468, 1997. (Pubitemid 28064611)
26. Bertsch T, Bleuel H, Deschl U and Rebel W: A new sensitive cardiac troponin T rapid test (TROPT) for the detection of experimental acute myocardial damage in rats. Exp Toxicol Pathol 57: 565-569, 1999. (Pubitemid 30016193)
27. Kumar V, Abbas AK and Fausto N: Pathologic Basis of Disease. 7th ed. Philadelphia- Pennsylvania 19106, Elseviers Saunders, pp. 14-21, 575-583, 2005.
28. Todd GL, Baroldi G, Pieper GM, Clayton FC and Eliot RS: Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J Mol Cell Cardiol 17: 317-338, 1985.
29. Rona G: Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306, 1985.
30. Del Rio D, Stewart AJ and Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metabol Cardiovas Dis 15: 316-328, 2005.
31. •OH generation on myocardial ischemic injury by dialysis technique. Am J Physiol 266: H903-H908, 1994.
32. Valenzuela A: The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci 48: 301-309, 1991.
33. Long J, Wang X, Gao H, Liu Z, Liu C, Miao M and Liu J: Malonaldehyde acts as a mitochondrial toxin: Inhibitory effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Life Sci 79: 1466-1472, 2006.
34. Koster JF, Slee RG, Essed CE and Stam H: Studies on cumene hydroperoxide-induced lipid peroxidation in the isolated perfused rat heart. J Mol Cell Cardiol 17: 701-708, 1985.
35. 2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproterenol and organic Ca antagonists (iproveratril, D 600, prenylamine). Pflugers Archiv - Eur J Physiol 312: R8-R9, 1969.
36. Fleckenstein A, Janke J, Doring HJ and Leder O: Myocardial fiber necrosis due to intracellular Ca overload a new principle in cardiac pathophysiology. Rec Adv Stud Card Struct Metab 4: 563-580, 1974.
37. Thollon C, Iliou JP, Cambarrat C, Robin F and Vilaine JP: Nature of the cardiomyocyte injury induced by lipid hydroperoxides. Cardiovas Res 30: 648-655, 1995.
38. Cao ZF: Scavenging effect of tetrandrine of active oxygen radicals. Planta Med 62: 413-414, 1996.
39. Castranova V: Generation of oxygen radicals and mechanisms of injury prevention. Environm Health Perspect 102 suppl: 65-68, 1994.
40. King VF, Garcia ML, Himmel D, Reuben JP, Lam YK, Pan JX, Han GQ and Kaczorowski GJ: Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J Biol Chem 263: 2238-2244, 1988.
41. Ingram GI, Jones RV, Hershgold J, Denson KW and Perkins JR: Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Br J Haematol 35: 81-100, 1977.
42. Pratico D, Ferro D, Iuliano L, Rokach J, Conti F, Valesini G, Fitzgerald GA and Violi F: Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation. Blood 93: 3401-3407, 1999.
43. Jackson CM: The biochemistry of prothrombin activation. Br J Haematol 39: 1-8, 1978.
44. 2+ channel alpha 1 subunit. Biochem 34: 9350-9355, 1995.